Naptumomab Biosimilar - Research Grade

Naptumomab Biosimilar - Research Grade, Human IgG1-Kappa
SKU
ICH5007-100MG
Packaging Unit
100mg
Manufacturer
Ichorbio

Availability: loading...
Price is loading...
Target: 5T4.

Specificity: Detects human 5T4. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Naptumomab.

Purification method: This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Background: Naptumomab is a fusion protein consisting of the antigen-binding fragment (Fab) of a monoclonal antibody with the superantigen staphylococcal enterotoxin A (SEA/E-120, "estafenatox"). The Fab binds to 5T4, an antigen expressed by various tumor cells, and the superantigen induces an immune response by activating T lymphocytes.

Concentration: 5mg/ml.

Formulation: Sterile, preservative-free, solution in PBS. BSA and Azide free.

Purity: >95% by SDS-PAGE.

Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method.

Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.
More Information
SKU ICH5007-100MG
Manufacturer Ichorbio
Manufacturer SKU ICH5007-100MG
Package Unit 100mg
Quantity Unit STK
Reactivity Human
Clonality Monoclonal
Application Functional Assay
Isotype Human IgG1-Kappa
Product information (PDF) Download
MSDS (PDF) Download